Clinical trial
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
NCT00237016 · Medical Corps, Israel Defense Force, Other · Completed
Key facts
| NCT number | NCT00237016 |
|---|---|
| Title | Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever |
| Official title | Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever |
| Lead sponsor | Medical Corps, Israel Defense Force, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Relapsing Fever, Tick-borne, Jarisch Herxheimer Reaction |
| Intervention type | Drug |
| Interventions | doxycycline treatment |
| Enrollment | 140 |
| Start date | Apr 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Oct 12, 2005 |
| Last update posted | Dec 19, 2024 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: